Vifor Fresenius Medical Care Renal Pharma Ltd. et al v. Annora Pharma Private Limited et al
Vifor Fresenius Medical Care Renal Pharma Ltd. and Vifor Fresenius Medical Care Renal Pharma France S.A.S. |
Annora Pharma Private Limited and Hetero Labs Limited |
1:2018cv01996 |
December 17, 2018 |
US District Court for the District of Delaware |
Leonard P Stark |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on April 30, 2020. A more recent docket listing may be available from PACER.
Document Text |
---|
Pro Hac Vice Attorney Raymond N. Nimrod for Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
SO ORDERED, re #10 STIPULATION TO EXTEND TIME to Respond to Complaint to February 22, 2019 filed by Annora Pharma Private Limited, Hetero Labs Limited. Signed by Judge Leonard P. Stark on 2/11/19. (ntl) |
Filing 10 STIPULATION TO EXTEND TIME Resond to Complaint to February 22, 2019 - filed by Annora Pharma Private Limited, Hetero Labs Limited. (Dorsney, Kenneth) |
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Raymond N. Nimrod, Steven C. Cherny, Matthew A. Traupman, Lauren N. Martin, and Nancy L. Zhang filed by Vifor Fresenius Medical Care Renal Pharma Ltd., Vifor Fresenius Medical Care Renal Pharma France S.A.S. Signed by Judge Leonard P. Stark on 2/8/19. (ntl) |
Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Raymond N. Nimrod, Steven C. Cherny, Matthew A. Traupman, Lauren N. Martin, and Nancy L. Zhang - filed by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd.. (Farnan, Brian) |
SO ORDERED, re #8 STIPULATION TO EXTEND TIME for Defendants Annora Pharma Ltd. and Hetero Labs Limited to answer, move or otherwise respond to the Complaint to February 8, 2019 filed by Annora Pharma Private Limited, Hetero Labs Limited. Signed by Judge Leonard P. Stark on 1/25/19. (ntl) |
Filing 8 STIPULATION TO EXTEND TIME for Defendants Annora Pharma Ltd. and Hetero Labs Limited to answer, move or otherwise respond to the Complaint to February 8, 2019 - filed by Annora Pharma Private Limited, Hetero Labs Limited. (Dorsney, Kenneth) |
SO ORDERED, re #7 STIPULATION TO EXTEND TIME for Defendants Annora Pharma Private Ltd. and Hetero Labs Limited to answer, move or otherwise respond to the Complaint to January 25, 2019 filed by Annora Pharma Private Limited, Hetero Labs Limited. Signed by Judge Leonard P. Stark on 1/10/19. (ntl) |
Filing 7 STIPULATION TO EXTEND TIME for Defendants Annora Pharma Private Ltd. and Hetero Labs Limited to answer, move or otherwise respond to the Complaint to January 25, 2019 - filed by Annora Pharma Private Limited, Hetero Labs Limited. (Dorsney, Kenneth) |
Filing 6 SUMMONS Returned Executed by Vifor Fresenius Medical Care Renal Pharma Ltd., Vifor Fresenius Medical Care Renal Pharma France S.A.S.. Annora Pharma Private Limited served on 12/19/2018, answer due 1/9/2019; Hetero Labs Limited served on 12/21/2018, answer due 1/11/2019. (Farnan, Michael) |
Summons Reissued with Magistrate Consent Notice attached as to Hetero Labs Limited. (ceg) |
Summons Reissued with Magistrate Consent Notice attached as to Annora Pharma Private Limited. (nmg) |
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Vifor Pharma AG, Corporate Parent Fresenius Medical Care AG & Co. KGaA for Vifor Fresenius Medical Care Renal Pharma Ltd.; Corporate Parent Vifor Fresenius Medical Care Renal Pharma Ltd. for Vifor Fresenius Medical Care Renal Pharma France S.A.S. filed by Vifor Fresenius Medical Care Renal Pharma France S.A.S., Vifor Fresenius Medical Care Renal Pharma Ltd.. (lak) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,561,251 B2. (lak) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/30/2018. Date of Expiration of Patent: 1/23/2030.Thirty Month Stay Deadline: 5/30/2021. (lak) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Annora Pharma Private Limited, Hetero Labs Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2526910.) - filed by Vifor Fresenius Medical Care Renal Pharma Ltd., Vifor Fresenius Medical Care Renal Pharma France S.A.S.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(lak) |
Summons Issued with Magistrate Consent Notice attached as to Annora Pharma Private Limited on 12/17/2018; Hetero Labs Limited on 12/17/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.